These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6436568)

  • 1. [In vitro antituberculous activity of DL8280 on Mycobacterium tuberculosis. The mode of bacteriostatic activity, bactericidal activity, cross-resistance and combined effect with other antituberculous agent].
    Tsukamura M; Mizuno S; Sotoyama H
    Kekkaku; 1984 Jul; 59(7):429-34. PubMed ID: 6436568
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro antituberculosis activity of a new antibacterial substance ofloxacin (DL8280).
    Tsukamura M
    Am Rev Respir Dis; 1985 Mar; 131(3):348-51. PubMed ID: 3919625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Studies on the ofloxacin resistance of tubercle bacilli].
    Tsukamura M; Mizuno S
    Kekkaku; 1985 Oct; 60(10):517-21. PubMed ID: 3935845
    [No Abstract]   [Full Text] [Related]  

  • 4. [Resistance pattern of Mycobacterium tuberculosis strain H37Rv to a new antibiotic DL 8280].
    Tsukamura M
    Kekkaku; 1984 May; 59(5):337-9. PubMed ID: 6434783
    [No Abstract]   [Full Text] [Related]  

  • 5. [In vitro and in vivo activities of norfloxacin, ofloxacin and ciprofloxacin against various mycobacteria].
    Saito H; Sato K; Tomioka H; Watanabe T
    Kekkaku; 1987 May; 62(5):287-94. PubMed ID: 3114537
    [No Abstract]   [Full Text] [Related]  

  • 6. [In vitro activity of ciprofloxacin and ofloxacin against Mycobacterium tuberculosis, M. avium, M. africanum, M. kansasii and BCG strains].
    Thomas L; Naumann P; Crea A
    Immun Infekt; 1986 Nov; 14(6):203-7. PubMed ID: 3100424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the resazurin microtiter assay for rapid detection of ofloxacin resistance in M. tuberculosis.
    Umubyeyi AN; Martin A; Zissis G; Struelens M; Karita E; Portaels F
    Int J Tuberc Lung Dis; 2006 Jul; 10(7):808-11. PubMed ID: 16848345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antituberculous action of a new antibiotic, Lividomycin. Effect on experimental tuberculosis of mice and cross resistance with other antituberculous agents].
    Tsukamura M; Mizuno S; Yamamoto M
    Kekkaku; 1970 Aug; 45(8):263-72. PubMed ID: 4989999
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapeutic effect of ofloxacin on mice challenged by ofloxacin-resistant Mycobacterium bovis strains].
    Tsukamura M
    Kekkaku; 1987 Apr; 62(4):235-8. PubMed ID: 3306084
    [No Abstract]   [Full Text] [Related]  

  • 10. Ofloxacin: in vitro and in vivo activity.
    Guerra L; Caro B; Erani E; Xerri L
    Chemioterapia; 1987 Feb; 6(1):23-31. PubMed ID: 3470154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Studies on antituberculous activity of lividomycin in vitro].
    Horai Z; Shimizu K; Yamamoto K; Fujisawa Y; Yamashita K
    Kekkaku; 1971 Oct; 46(10):401-4. PubMed ID: 5004573
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro susceptibility testing of levofloxacin and ofloxacin by microtiter plate Alamar blue against multidrug and non multidrug resistant Mycobacterium tuberculosis in Thailand.
    Pracharktam R; Angkananukool K; Vibhagool A
    J Med Assoc Thai; 2001 Sep; 84(9):1241-5. PubMed ID: 11800295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies on antituberculotic activity of delta-hydroxy-gamma-oxo-L-norvaline (HON). 3. In vitro antituberculotic activity of HON in the combined use of various antituberculotic agents and mode of acquiring resistance in the interaction of drugs].
    Kamada M
    Bull Chest Dis Res Inst Kyoto Univ; 1968 Sep; 2(1):124-36 passim. PubMed ID: 4979432
    [No Abstract]   [Full Text] [Related]  

  • 14. [In vitro antimycobacterial activity of a new quinolone, T-3761].
    Tomioka H; Sato K; Saito H
    Kekkaku; 1995 Feb; 70(2):97-101. PubMed ID: 7699982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experimental studies in vitro on the antituberculous activities of 27753RP (R.P), a semisynthetic derivative of griselimycine. III. Cross resistance of R.P].
    Shibata A
    Bull Chest Dis Res Inst Kyoto Univ; 1984 Mar; 17(1-2):38-42. PubMed ID: 6442174
    [No Abstract]   [Full Text] [Related]  

  • 16. [In vitro antituberculous activity of ofloxacin and levofloxacin against multidrug-resistant tuberculosis and clinical outcomes].
    Tada A; Kawata N; Shibayama T; Takahashi S; Hirano A; Kimura G; Takeuchi M; Okada C; Soda R; Takahashi K
    Kekkaku; 2006 Apr; 81(4):337-44. PubMed ID: 16715942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of in vitro synergy when three antimicrobial agents are combined against Mycobacterium tuberculosis.
    Bhusal Y; Shiohira CM; Yamane N
    Int J Antimicrob Agents; 2005 Oct; 26(4):292-7. PubMed ID: 16150578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergence of ofloxacin resistance in Mycobacterium tuberculosis clinical isolates from China as determined by gyrA mutation analysis using denaturing high-pressure liquid chromatography and DNA sequencing.
    Shi R; Zhang J; Li C; Kazumi Y; Sugawara I
    J Clin Microbiol; 2006 Dec; 44(12):4566-8. PubMed ID: 17035499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experimental studies in vitro on the antituberculous activities of 27753 (R.P), a semisynthetic derivative of griselimycine. II. Antituberculous activities of R.P. in combination with other antituberculous agents].
    Shibata A
    Bull Chest Dis Res Inst Kyoto Univ; 1984 Mar; 17(1-2):32-7. PubMed ID: 6442173
    [No Abstract]   [Full Text] [Related]  

  • 20. [The antibacterial activity in vitro of ofloxacin in comparison with other orally administered antimicrobial substances on ampicillin-resistant clinical isolates].
    Seibert G; Klesel N; Limbert M; Schrinner E; Winkler I
    Arzneimittelforschung; 1984; 34(11):1552-4. PubMed ID: 6596953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.